Confirmed bacillus anthracis infection among persons who inject drugs, Scotland, 2009-2010

Emerging Infectious Diseases

Volumn 20, Issue 9, 2014, Pages 1452-1463

  Booth, Malcolm ^a   Donaldson, Lindsay ^a   Cui, Xizhong ^b   Sun, Junfeng ^b   Cole, Stephen ^c   Dailsey, Susan ^d   Hart, Andrew ^a   Johns, Neil ^e   McConnell, Paul ^f   McLennan, Tina ^g   Parcell, Benjamin ^c   Robb, Henry ^h   Shippey, Benjamin ^e   Sim, Malcolm ⁱ   Wallis, Charles ^j   Eichacker, Peter Q ^b  

^a GLASGOW ROYAL INFIRMARY   (United Kingdom)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

^c NINEWELLS HOSPITAL   (United Kingdom)

^d VICTORIA INFIRMARY   (United Kingdom)

^e VICTORIA HOSPITAL   (United Kingdom)

^f CROSSHOUSE HOSPITAL   (United Kingdom)

^g HAIRMYRES HOSPITAL   (United Kingdom)

^h FORTH VALLEY ROYAL HOSPITAL   (United Kingdom)

ⁱ WESTERN INFIRMARY   (United Kingdom)

^j WESTERN GENERAL HOSPITAL   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; BICARBONATE; BILIRUBIN; C REACTIVE PROTEIN; CALCIUM; CEFTRIAXONE; CIPROFLOXACIN; CLINDAMYCIN; CORTICOSTEROID; CREATININE; CRYOGLOBULIN; FIBRINOGEN; FLUCLOXACILLIN; FRESH FROZEN PLASMA; GENTAMICIN; HEMOGLOBIN; MEROPENEM; METRONIDAZOLE; PENICILLIN G; PIPERACILLIN PLUS TAZOBACTAM; POTASSIUM; SODIUM; VANCOMYCIN; ANTISERUM; VASOCONSTRICTOR AGENT;

ABDOMINAL PAIN; ADULT; ANTHRAX; ARTICLE; ARTIFICIAL VENTILATION; BACILLUS ANTHRACIS; BODY TEMPERATURE; BREATHING RATE; CLINICAL ARTICLE; DRUG ABUSE; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHEMA; ERYTHROCYTE CONCENTRATE; FEMALE; GLASGOW COMA SCALE; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INJECTION SITE PAIN; INTENSIVE CARE UNIT; INTERNATIONAL NORMALIZED RATIO; MALE; MORTALITY; OXYGEN THERAPY; PARTIAL THROMBOPLASTIN TIME; POLYMERASE CHAIN REACTION; RENAL REPLACEMENT THERAPY; RETROSPECTIVE STUDY; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURGERY; SURVIVOR; SWELLING; SYSTOLIC BLOOD PRESSURE; UNITED KINGDOM; DRUG USE; EPIDEMIC; HEALTH SURVEY; HISTORY; RISK FACTOR; TRANSMISSION;

ADULT; ANTHRAX; BACILLUS ANTHRACIS; DISEASE OUTBREAKS; DRUG USERS; HISTORY, 21ST CENTURY; HUMANS; IMMUNE SERA; PUBLIC HEALTH SURVEILLANCE; RISK FACTORS; SCOTLAND; VASOCONSTRICTOR AGENTS;

EID: 84906218577     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid2009.131481     Document Type: Article

References (32)

1. Sweeney DA, Hicks CW, Cui X, Li Y, Eichacker PQ. Anthrax infection. Am J Respir Crit Care Med. 2011;184:1333-41. http://dx.doi. org/10.1164/rccm.201102-0209CI
2. Booth MG, Hood J, Brooks TJ, Hart A. Anthrax infection in drug users. Lancet. 2010;375:1345-6. http://dx.doi.org/10.1016/S0140-6736(10)60573-9
3. Health Protection Scotland. An outbreak of anthrax among drug users in Scotland, December 2009 to December 2010. A report on behalf of the National Anthrax Outbreak Control Team [cited 2013 May 30]. http://www.documents.hps.scot.nhs.uk/giz/anthraxoutbreak/ anthrax-outbreak-report-2011-12.pdf
4. Grunow R, Klee SR, Beyer W, George M, Grunow D, Barduhn A, et al. Anthrax among heroin users in Europe possibly caused by same Bacillus anthracis strain since 2000. Euro Surveill. 2013;18:pii: 20437.
5. Ringertz SH, Hoiby EA, Jensenius M, Maehlen J, Caugant DA, Myklebust A, et al. Injectional anthrax in a heroin skin-popper. Lancet. 2000;356:1574-5. http://dx.doi.org/10.1016/S0140-6736(00)03133-0
6. Palmateer NE, Ramsay CN, Browning L, Goldberg DJ, Hutchinson SJ. Anthrax infection among heroin users in Scotland during 2009-2010: a case-control study by linkage to a national drug treatment database. Clin Infect Dis. 2012;55:706-10. http://dx.doi.org/10.1093/cid/cis511
7. Price EP, Seymour ML, Sarovich DS, Latham J, Wolken SR, Mason J, et al. Molecular epidemiologic investigation of an anthrax outbreak among heroin users, Europe. Emerg Infect Dis. 2012;18:1307-13. http://dx.doi.org/10.3201/eid1808.111343
8. Beaumont G. Anthrax in a Scottish intravenous drug user. J Forensic Leg Med. 2010;17:443-5. http://dx.doi.org/10.1016/j.jflm.2010.09.008
9. Jallali N, Hettiaratchy S, Gordon AC, Jain A. The surgical management of injectional anthrax. J Plast Reconstr Aesthet Surg. 2011;64:276-7. http://dx.doi.org/10.1016/j.bjps.2010.06.003
10. Johns N, Cooper D, Terrace J. An unusual case of peritonitis in an intravenous drug user. Gastroenterology. 2011;141:435-6, 780-1. http://dx.doi.org/10.1053/j.gastro.2011.02.076
11. Knox D, Murray G, Millar M, Hamilton D, Connor M, Ferdinand RD, et al. Subcutaneous anthrax in three intravenous drug users: a new clinical diagnosis. J Bone Joint Surg Br. 2011;93:414-7. http://dx.doi.org/10.1302/0301-620X.93B3.25976
12. Parcell BJ, Wilmshurst AD, France AJ, Motta L, Brooks T, Olver WJ. Injection anthrax causing compartment syndrome and necrotising fasciitis. J Clin Pathol. 2011;64:95-6. http://dx.doi. org/10.1136/jcp.2010.082586
13. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H, et al. The SOFA (sepsis-related organ failure assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med. 1996;22:707-10. http://dx.doi.org/10.1007/BF01709751
14. Holty JE, Bravata DM, Liu H, Olshen RA, McDonald KM, Owens DK. Systematic review: a century of inhalational anthrax cases from 1900 to 2005. Ann Intern Med. 2006;144:270-80. http://dx.doi.org/10.7326/0003-4819-144-4-2006022 10-00009
15. Ebright JR, Pieper B. Skin and soft tissue infections in injection drug users. Infect Dis Clin North Am. 2002;16:697-712. http://dx.doi. org/10.1016/S0891-5520(02)00017-X
16. Doganay L, Welsby PD. Anthrax: a disease in waiting? Postgrad Med J. 2006;82:754-6. http://dx.doi.org/10.1136/pgmj.2005.044487
17. Doganay M, Metan G, Alp E. A review of cutaneous anthrax and its outcome. J Infect Public Health. 2010;3:98-105. http://dx.doi. org/10.1016/j.jiph.2010.07.004
18. Cui X, Su J, Li Y, Shiloach J, Solomon S, Kaufman JB, et al. Bacillus anthracis cell wall produces injurious inflammation but paradoxically decreases the lethality of anthrax lethal toxin in a rat model. Intensive Care Med. 2010;36:148-56. http://dx.doi.org/10.1007/ s00134-009-1643-9
19. Langer M, Malykhin A, Maeda K, Chakrabarty K, Williamson KS, Feasley CL, et al. Bacillus anthracis peptidoglycan stimulates an inflammatory response in monocytes through the p38 mitogenactivated protein kinase pathway. PLoS ONE. 2008;3:e3706. http://dx.doi.org/10.1371/journal.pone.0003706
20. Popov SG, Villasmil R, Bernardi J, Grene E, Cardwell J, Popova T, et al. Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells. FEBS Lett. 2002;527:211-5. http://dx.doi. org/10.1016/S0014-5793(02)03228-3
21. Qiu P, Li Y, Shiloach J, Cui X, Sun J, Trinh L, et al. Bacillus anthracis cell wall peptidoglycan but not lethal or edema toxins produces changes consistent with disseminated intravascular coagulation in a rat model. J Infect Dis. 2013;208:978-89. http://dx.doi.org/10.1093/ infdis/jit247
22. Hicks CW, Cui X, Sweeney DA, Li Y, Barochia A, Eichacker PQ. The potential contributions of lethal and edema toxins to the pathogenesis of anthrax associated shock. Toxins. 2011;3:1185-202. http://dx.doi.org/10.3390/toxins3091185
23. Moayeri M, Leppla SH. Cellular and systemic effects of anthrax lethal toxin and edema toxin. Mol Aspects Med. 2009;30:439-55. http://dx.doi.org/10.1016/j.mam.2009.07.003
24. Dworkin MS, Westercamp MD, Park L, McIntyre A. The epidemiology of necrotizing fasciitis including factors associated with death and amputation. Epidemiol Infect. 2009;137:1609-14. http://dx.doi. org/10.1017/S0950268809002532
25. Frazee BW, Fee C, Lynn J, Wang R, Bostrom A, Hargis C, et al. Community-acquired necrotizing soft tissue infections: a review of 122 cases presenting to a single emergency department over 12 years. J Emerg Med. 2008;34:139-46. http://dx.doi.org/10.1016/ j.jemermed.2007.03.041
26. Yaghoubian A, de Virgilio C, Dauphine C, Lewis RJ, Lin M. Use of admission serum lactate and sodium levels to predict mortality in necrotizing soft-tissue infections. Arch Surg. 2007;142:840-6, discussion 4-6. http://dx.doi.org/10.1001/archsurg.142.9.840
27. Sherer K, Li Y, Cui X, Eichacker PQ. Lethal and edema toxins in the pathogenesis of Bacillus anthracis septic shock: implications for therapy. Am J Respir Crit Care Med. 2007;175:211-21. http://dx.doi.org/10.1164/rccm.200608-1239CP
28. Abramova FA, Grinberg LM, Yampolskaya OV, Walker DH. Pathology of inhalational anthrax in 42 cases from the Sverdlovsk outbreak of 1979. Proc Natl Acad Sci U S A. 1993;90:2291-4. http://dx.doi. org/10.1073/pnas.90.6.2291
29. Grinberg LM, Abramova FA, Yampolskaya OV, Walker DH, Smith JH. Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod Pathol. 2001;14:482-95. http://dx.doi.org/10.1038/modpathol.3880337
30. Chan T, Yaghoubian A, Rosing D, Kaji A, de Virgilio C. Low sensitivity of physical examination findings in necrotizing soft tissue infection is improved with laboratory values: a prospective study. Am J Surg. 2008;196:926-30, discussion 30. http://dx.doi.org/10.1016/ j.amjsurg.2008.07.025
31. Su YC, Chen HW, Hong YC, Chen CT, Hsiao CT, Chen IC. Laboratory risk indicator for necrotizing fasciitis score and the outcomes. ANZ J Surg. 2008;78:968-72. http://dx.doi.org/10.1111/j.1445-2197.2008.04713.x
32. Holzmann T, Frangoulidis D, Simon M, Noll P, Schmoldt S, Hanczaruk M, et al. Fatal anthrax infection in a heroin user from southern Germany, June 2012. Euro Surveill. 2012;17:20204.